Oral polio vaccines and their role in polio eradication in India

Expert Review of Vaccines

Volumn 8, Issue 1, 2009, Pages 35-41

  Paul, Yash ^a,b  

^a Maharaja Agrasen Hospital   (India)

^b Bani Park   (India)

Author keywords

Genetic factor; Polio; Polio eradication; Polio eradication in India; Vaccine failure

Indexed keywords

INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE;

DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; HEALTH PROGRAM; HEREDITY; HUMAN; INDIA; INFECTION CONTROL; INFECTION PREVENTION; OUTCOME ASSESSMENT; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW;

HUMANS; INDIA; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL;

EID: 58149400835     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.8.1.35     Document Type: Review

References (29)

1. Paul Y. What needs to be done for polio eradication in India? Vaccine 25, 6431-6436 (2007).
2. Mittal SK, Mathew JL. Polio eradication in India: the way forward. Indian J. Pediatr. 74, 153-160 (2007).
3. Strebel PM, Sutter RW, Cochi SL et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin. Infect. Dis. 14, 568-579 (1992).
4. Nkowane BM, Wassilak SGF, Orenstein WA et al. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 257, 1335-1340 (1987).
5. Andrus JK, Strebel PM, de Quadros CA, Olive JM. Risk of vaccine-associated paralytic poliomyelitis in Latin America 1989-1981. Bull. World Health Organ. 73, 33-40 (1995).
6. Kohler KA, Bannerjee K, Hlady WG, Andrus JK, Sutter RW. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Bull. World Health Organ. 80, 210-216 (2002).
7. Paul Y. Accuracy of the National Polio Surveillance Project Data in Rajasthan. Indian J. Pediatr. 69, 667-673 (2002).
8. Paul Y. Why has polio eradication program failed in India? Indian Pediatr. 45, 381-388 (2008).
9. Grassly NC, Frazer C, Wenger J et al. New strategies for elimination of polio from India. Science 314, 1150-1153 (2006).
10. Paul Y. Role of genetic factors in polio eradication: new challenge for policy makers. Vaccine 25, 8365-8371 (2007). • Presents observations that suggest the role of genetic factors.
11. Lee LH, Wenner HA, Rosen L. Prevention of poliomyelitis in Singapore by live vaccine. Br. Med. J. 1, 1077-1080 (1964).
12. Poliomyelitis Commission, Western Region Ministry of Health, Nigeria. Poliomyelitis vaccination in Ibadan, Nigeria during 1964 with oral vaccine. Bull. World Health Organ. 34, 865-876 (1966).
13. Drozdov SG, Cockburn WC. Poliomyelitis in the world. Bull. World Health Organ. 42(3), 405-417 (1970).
14. Melnick JL. Advantages and disadvantages of killed and live poliomyelitis vaccine. Bull. World Health Organ. 56, 21-38 (1978).
15. John TJ. Problems with oral poliovaccine in India. Indian Pediatr. 9, 252-256 (1972).
16. John TJ, Jayabal P. Oral polio vaccination of children in tropics. The poor seroconversion rates and the absence of viral interference. Am. J. Epidemiol. 96, 263-269 (1972).
17. John TJ. Antibody response of infants in tropics to five doses of oral poliovaccine. Br. Med. J. 1, 811-812 (1976).
18. Poland GA, Jacob RM. The genetic basis for variation in antibody response to vaccines. Curr. Opin. Pediatr. 10, 208-215 (1998). • Describes the role of genetic factors in response to vaccines and development of resistant microorganisms.
19. Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes Immun. 5, 122-129 (2004). • Describes the role of genetic factors in response to vaccines, including the oral polio vaccine.
20. du chatelet IP, Merchant AT, Fisher-Hoch S et al. Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules. Vaccine 21, 1710-1718 (2003).
21. Ahuja B, Gupta VK, Tyagi A. Paralytic poliomyelitis (1989-1994): report from a Sentinel Center. Indian Pediatr. 33, 734-745 (1996).
22. Paul Y. Polio eradication strategy: need for re-appraisal. Indian Pediatr. 37, 913-916 (2000).
23. Paul Y. OPV cannot eradicate polio from India: do we need any further evidence? Vaccine 26, 2058-2061 (2008).
24. Sutter RW, Jafari H, Aylward B. IAP recommendations on polio eradication and improvement of routine immunization. Indian Pediatr. 45, 353-355 (2008).
25. Paul Y. Let us face the facts and accept the reality. Indian Pediatr. 42, 728-729 (2005).
26. Swartz TA, Handsher R, Manor Y et al. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Isreal: impact on the control of poliomyelitis. Vaccine 16, 2090-2095 (1998).
27. Heymann DL, Sutter RW, Aylward RB. Polio eradication: interrupting transmission, towards a polio free world. Future Virol. 1, 181-188 (2006).
28. Faden H, Duff L, Sun M, Shuff C. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced potency inactivated trivalent poliovirus vaccines. J. Infect. Dis. 168, 452-454 (1993).
29. National Polio Surveillance Project www.npspindia.org • Presently, the National Polio Surveillance Project is the only source for polio-related data. The author has utilized the official data available here, and line lists from Rajasthan, for analysis.